Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07395128 · ClinicalTrials.gov registry record · Phase 1
Lateral Plantar Artery Embolization For Plantar Fasciitis
A Phase 1 study of Plantar Fasciitis and Plantar Fasciitis, Chronic, sponsored by Joint & Vascular Institute.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT07395128: Recruiting Phase 1 study of Plantar Fasciitis and Plantar Fasciitis, Chronic, sponsored by Joint & Vascular Institute.
NCT07395128 is a Phase 1 study of Plantar Fasciitis and Plantar Fasciitis, Chronic that is actively recruiting participants, run by Joint & Vascular Institute. The registered enrollment target is 10 participants, below the 107-participant average among 6 other Plantar Fasciitis trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07395128, a Phase 1 study of Plantar Fasciitis and Plantar Fasciitis, Chronic, is actively recruiting participants, sponsored by Joint & Vascular Institute.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to learn if lateral plantar artery embolization using Lipiodol can safely and effectively treat chronic heel pain due to plantar fasciitis in adults aged 25 to 80. The main questions it aims to answer are: Does this procedure successfully reduce chronic heel pain as measured by the Visual Analog Scale (VAS) over 12 months? How safe is the procedure, specifically regarding the frequency of serious medical problems or adverse events related to the device? Participants will: Undergo a minimally invasive procedure where a doctor uses a small tube (catheter) to inject a temporary blocking agent (LipioJoint) into specific blood vessels in the foot. Receive a phone call one day after the procedure to check for early side effects. Participate in four follow-up telehealth visits over the course of one year (at 1, 3, 6, and 12 months). Complete pain intensity surveys (VAS) and report any changes in their use of other therapies or medications during these visits.
Primary Outcome
Pain - measured via VAS at baseline, 1-month, 3-month, 6-month, and 12-month follow-up
Conditions Studied
Interventions
- DEVICE Lipiodol
Study Locations (1)
Illinois
- Joint and Vascular Institute - Libertyville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2025-12-20 |
| Est. Completion | 2027-03 |
| Phase | Phase 1 |
What NCT07395128 shows while recruiting
NCT07395128 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 107-participant average among 6 other Plantar Fasciitis trials with a reported enrollment target (91% lower).
The record links to 2 conditions, with Plantar Fasciitis appearing as the primary indexed condition, and to 1 intervention - of which Lipiodol is the first listed.
NCT07395128 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT07395128 about?
NCT07395128 is a clinical study titled "Lateral Plantar Artery Embolization For Plantar Fasciitis". The goal of this clinical trial is to learn if lateral plantar artery embolization using Lipiodol can safely and effectively treat chronic heel pain due to plantar fasciitis in adults aged 25 to 80. The main questions it aims to answer are: Does this procedure successfully reduce chronic heel pain ...
What is the current status of trial NCT07395128?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2025-12-20. Estimated completion is 2027-03.
What conditions does trial NCT07395128 study?
This clinical trial studies the following conditions: Plantar Fasciitis, Plantar Fasciitis, Chronic.
What interventions are being tested in trial NCT07395128?
The interventions under investigation include: Lipiodol (DEVICE).
Who is sponsoring clinical trial NCT07395128?
This trial is sponsored by Joint & Vascular Institute, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07395128 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Plantar Fasciitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Effects of Terrain Variation on Intrinsic Foot Musculature in Healthy Individuals and Individuals With Plantar Fasciitis
RECRUITING · NA
-
Phase 2 DaxibotulinumtoxinA for Injection for the Management of Plantar Fasciitis
COMPLETED · Phase 2
-
Treatment of Plantar Fasciitis With Dorsiflexion Night Splints and Medial Arch Supports
COMPLETED · Phase 4
-
Study of Effectiveness and Safety of Extracorporeal Shock Wave Therapy (ESWT) for Treatment of Painful Heel Syndrome
COMPLETED · Phase 3
-
DaxibotulinumtoxinA for Injection for the Treatment of Plantar Fasciitis
COMPLETED · Phase 2
-
Comparative Study of Amniotic Membrane Injectable in the Treatment of Recalcitrant Plantar Fasciitis
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI